Friday 9 May 2014

Glenmark Pharmaceuticals has reported results for fourth quarter and year ended March 31, 2014

The company has posted a rise of 78.61% in its net profit at Rs 151.66 crore for the quarter ended March 31, 2014 as compared to Rs 84.91 crore for the same quarter in the previous year. Total income of the company increased by 34.28% at Rs 687.25 crore for quarter under review as compared to Rs 511.79 crore for the quarter ended March 31, 2013.
On consolidated basis, the company has reported 74.97% fall in its net profit at Rs 43.06 crore for the quarter ended March 31, 2014 as compared to Rs 172.08 crore for the same quarter in the previous year. However, total income of the company has increased by 27.09% at Rs 1691.48 crore for quarter under review as compared to Rs 1330.90 crore for the quarter ended March 31, 2013.
For the year ended March 31, 2014, the company has posted a jump of 12.35% in its net profit at Rs 433.82 crore as compared to Rs 386.10 crore for the same period in the previous year. Total income of company improved by 14.64% at Rs 2368.03 crore for year under review as compared to Rs 2065.54 crore for the period ended March 31, 2013.
For the year ended March 31, 2014, on the consolidated basis, the company has posted a fall of 12.54% in its net profit at Rs 542.27 crore as compared to Rs 620.03 crore for the same period in the previous year. However, total income of company has increased by 19.78% at Rs 6016.68 crore for year under review as compared to Rs 5023.08 crore in the previous fiscal.

No comments:

Post a Comment